AUSTER MARTIN (Chief Financial Officer) sold 30.6% of their position (21K shares) of VENTYX BIOSCIENCES, INC. on the open market
Open‑market sale worth $646.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/5/2023ACC: 0001209191-23-023474
Officer· Chief Financial Officer
Since Oct 2021
-21K
Net shares
Net seller
$646.0K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
21K acquired · 42K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+21K
Price / share
$3.45
Trade value
$72.45K
% of position
44.1%
4/4/2023
47.65K→68.65K
Common Stock
Direct
Shares
−9.58K
Price / share
$30.24
Trade value
$289.64K
% of position
14.0%
4/4/2023
68.65K→59.07K
Common Stock
Direct
Shares
−9.54K
Price / share
$31.07
Trade value
$296.24K
% of position
16.1%
4/4/2023
59.07K→49.54K
Common Stock
Direct
Shares
−1.89K
Price / share
$31.86
Trade value
$60.15K
% of position
3.8%
4/4/2023
49.54K→47.65K
Total
Net shares
+0.00
Net value
-$573.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/4/2023 | M · Option Exercise | +21K | $3.45 | $72.45K | 44.1% | 47.65K | 68.65K |
| Common Stock Direct | 4/4/2023 | S · Sale | −9.58K | $30.24 | $289.64K | 14.0% | 68.65K | 59.07K |
| Common Stock Direct | 4/4/2023 | S · Sale | −9.54K | $31.07 | $296.24K | 16.1% | 59.07K | 49.54K |
| Common Stock Direct | 4/4/2023 | S · Sale | −1.89K | $31.86 | $60.15K | 3.8% | 49.54K | 47.65K |
| Total | +0.00 | -$573.58K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
21K shares
Shares
−21K
Strike price
3.45
Held after
310.18K
Exercisable
—
4/4/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock21K shares | 4/4/2023 | M · Option Exercise | −21K | 3.45 | — | 310.18K |